Celltrion Inc CONIF
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover CONIF, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Growth
- Total Number of Employees
- 2,277
- Website
- http://www.celltrion.com
Comparables
Valuation
|
Metric
|
CONIF
|
MRNA
|
002007
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 40.19 | 26.80 |
Price/Book Value | — | 2.98 | 2.91 |
Price/Sales | — | 6.11 | 6.45 |
Price/Cash Flow | — | — | 32.96 |
Price/Earnings
CONIF
MRNA
002007
Financial Strength
|
Metric
|
CONIF
|
MRNA
|
002007
|
|---|---|---|---|
Quick Ratio | 0.70 | 3.21 | 2.68 |
Current Ratio | 2.03 | 3.42 | 4.01 |
Interest Coverage | 68.46 | −113.82 | 140.38 |
Quick Ratio
CONIF
MRNA
002007
Profitability
|
Metric
|
CONIF
|
MRNA
|
002007
|
|---|---|---|---|
Return on Assets (Normalized) | 5.99% | −20.12% | — |
Return on Equity (Normalized) | 8.07% | −26.85% | — |
Return on Invested Capital (Normalized) | 6.66% | −26.68% | — |
Return on Assets
CONIF
MRNA
002007
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Lrswgfjxfr | Bfpd | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Nbzyhhmby | Fyzglyq | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Kygfbbn | Zkfrgk | $97.8 Bil | |
MRNA
| Moderna Inc | Qjlzyhgr | Mhts | $41.3 Bil | |
ARGX
| argenx SE ADR | Qpcmldnvh | Hmy | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Trqznkyx | Cqz | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Gftcxlg | Wnqkc | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Jqrbzkb | Cqcpyr | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Mstrsmxm | Msxhtn | $12.5 Bil | |
INCY
| Incyte Corp | Vtmcrpfsj | Zmvxr | $11.6 Bil |